Literature DB >> 25524931

Abiraterone acetate-induced life-threatening torsade de pointes.

Frederique Rodieux, Nathalie Nieto, Henri Sunthorn, Gregor John, Monica Escher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25524931     DOI： 10.1177/1060028014555362

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  4 in total

1.  Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes.

Authors:  Pietro Enea Lazzerini; Iacopo Bertolozzi; Maurizio Acampa; Silvia Cantara; Maria Grazia Castagna; Laura Pieragnoli; Antonio D'Errico; Marco Rossi; Stefania Bisogno; Nabil El-Sherif; Mohamed Boutjdir; Franco Laghi-Pasini; Pier Leopoldo Capecchi
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

2.  Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.

Authors:  Ximena Morales; Diego Garnica; Daniel Isaza; Nicolas Isaza; Felipe Durán-Torres
Journal:  BMC Cardiovasc Disord       Date:  2021-03-12       Impact factor: 2.298

3.  Abiraterone-induced refractory hypokalaemia and torsades de pointes in a patient with metastatic castration-resistant prostate carcinoma: a case report.

Authors:  Mariam Riad; Jeffery Scott Allison; Shahla Nayyal; AbdulWahab Hritani
Journal:  Eur Heart J Case Rep       Date:  2021-11-16

4.  A Case of Abiraterone-Related Hypokalemia Leading to Torsades de Pointes and Cardiac Arrest.

Authors:  Dae Hyun Lee; David B Money; Akshay Deshpande; Brian Samuels
Journal:  Cureus       Date:  2022-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.